Algarithm Ingredients launches new line of algal omega-3 concentrates
Algarithm Ingredients has launched a new line of algal omega-3 concentrates called thetamega3 for the North American market.
Photo © iStockphoto.com/ evemilla
Algarithm Ingredients (Saskatoon, Saskatchewan, Canada), an algal omega-3 producer, has launched a new line of algal omega-3 concentrates called thetamega3 for the North American market. Made in the United States in a world class facility, the final composition boasts less than 1% Ethyl Esters and over 90% Triglyceride (30% higher than the industry standard), The new line, enables innovative ingredient combinations and reduced capsule size, without sacrificing quality, dosage or affordability.
“While reviewing our supply chain, we found a unique, cost effective and sustainable way to create this new line of concentrates. The thetamega3 line allows us to offer customers greater formulation flexibility at a highly competitive price while reducing our environmental impact,” says Ben Kelly, Algarithm managing director, in a press release.
Thetamega3 is currently available in a 650 mg/g DHA formula, with a 750 mg/g DHA formula and EPA-only formula on the way.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
